← Back to Clinical Trials
Recruiting NCT05810129

NCT05810129 Crossed Education in Relation to Muscle Mass in Patients Operated of Clavicular Fracture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05810129
Status Recruiting
Phase
Sponsor Universidad de La Frontera
Condition Clavicle Fracture
Study Type INTERVENTIONAL
Enrollment 39 participants
Start Date 2023-05-02
Primary Completion 2025-07-31

Trial Parameters

Condition Clavicle Fracture
Sponsor Universidad de La Frontera
Study Type INTERVENTIONAL
Phase N/A
Enrollment 39
Sex MALE
Min Age 18 Years
Max Age 40 Years
Start Date 2023-05-02
Completion 2025-07-31
Interventions
concentric-eccentric strength trainingeccentric strength trainingstandard physical therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The immobilization process after an operation or injury in the upper extremity causes a loss of muscle mass and strength of 0.2% and 1.3% per day, respectively. Currently, the use of cross-education, which is unilateral training in the uninjured limb, during the immobilization period, is expanding, demonstrating a magnitude of strength gain in the immobilized limb from 8% to 77% of the mean of strength of the trained limb. Despite the evidenced benefits of cross-education in unilateral injuries such as distal radius fracture, anterior cruciate ligament injury, and knee replacement, very little is known about this effect in shoulder immobilization after clavicle fracture.

Eligibility Criteria

Inclusion Criteria: * Men from 18 to 40 years old, diagnosed with radiographically verified clavicle fracture and awaiting surgical procedure. They have a body mass index of not less than 18.5 and not more than 29.9 kg/m2 and sign an informed consent. Exclusion Criteria: * Patients with previous injuries, pathological fracture or polytrauma * Patients who report pain, a history of rotator cuff tear or surgery in the non-injured upper extremity. * Patients with uncontrolled cardiovascular diseases. * Any history of neurological problems in the upper extremities. * Use of nutritional supplementation (leucine, glutamine, casein, whey-protein, fatty acids and creatine) and/or Hormonal Replacement Therapy.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology